Cara Therapeutics Inc (NAS:CARA)
$ 0.2702 -0.0233 (-7.94%) Market Cap: 14.82 Mil Enterprise Value: -33.03 Mil PE Ratio: 0 PB Ratio: 1.39 GF Score: 31/100

Cara Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 04, 2020 / 03:00PM GMT
Release Date Price: $15.62 (-2.80%)
Operator

Greetings, and welcome to the Annual Meeting of Stockholders for Cara Therapeutics, Inc. I would now like to turn the conference call over to Mr. Derek Chalmers. Mr. Chalmers, the floor is yours, sir.

Derek T. Chalmers
Cara Therapeutics, Inc. - Co-Founder, President, CEO & Director

Great. Thank you. Good morning, everybody. I am Derek Chalmers. I'm the Chief Executive Officer for Cara Therapeutics, and I'm very happy to welcome you to the Cara Therapeutics 2020 Stockholders' Meeting.

Before I call the meeting to order, I'd like to introduce you to the other members of the Board and the business team who are present today. The other members of the Board here today are Dr. Jeffrey Ives, Harrison Bains Jr., Christopher Posner, Martin Vogelbaum. And Martin Vogelbaum also serves as the company's lead independent director.

The other officers of the company here today are Richard Makara, our Vice President, Head of Accounting and Controller; and Scott Terrillion, our General Counsel and Secretary. And Mr. Terrillion will act as secretary for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot